Silver News
New Catheter-Electrode System Features Silver
By Samuel Etris, Senior Technical Consultant to The Silver
Institute
A new catheter-electrode system, using a low-intensity current
to push bacteria and virus-fighting silver ions into the bloodstream,
has been patented by a Pennsylvania company.
The catheter combines a silver electrode inserted into the
patient's blood stream with a second electrode placed on the
nearby skin. The combined action releases silver ions into
the blood for immediate reaction with pathogens such as HIV
viruses. The silver ions do not attack normal human cells
because these cells have protective walls, which is not the
case for bacteria, viruses and fungi.
Studies revealed in U.S. Patent, No. 6,066,489 - assigned
to Arrow International, Inc. of Reading, Pennsylvania - show
improvement by HIV patients treated with in-blood silver ions.
One patient prior to treatment had over two million copies
of the HIV virus per milliliter of blood and had an infection
fighter cell (T4 cells) count of 18. The patient was experiencing
serious kidney malfunction. Within 24 hours after silver ion
treatment, the HIV virus count dropped to about one million
copies and T4 cells fell to 11. One month after treatment
began, the HIV virus count was again halved and the Patient's
overall health improved.
The catheter-electrode system is intended to be a universal
aid in treating blood-borne infections otherwise extremely
difficult to treat or cure once infection has begun. Blood-borne
viruses can completely overwhelm a patient, defeating the
immune system and leading to death.
The catheter electrode is 97.8 percent silver, 2 percent Platinum,
and 0.2 percent copper. The silver supplies the active silver
ion; platinum acts as a catalyst to aid in the release of
the silver ions and prevents a buildup of oxides on the electrode.
Copper controls the release rate of the silver from the electrode.
The small amount of silver introduced into the patient's bloodstream,
and the extremely low levels of current, are both highly effective
and physiologically safe.
Silver News - June / July 2001
|
